Featured Research

from universities, journals, and other organizations

In Gene Therapy First, Scientists Restore Vision To Dogs Born Blind

Date:
April 30, 2001
Source:
University Of Florida
Summary:
For the first time ever, animals that were born blind gained the ability to see after undergoing gene therapy, according to research from the University of Florida, Cornell University and the University of Pennsylvania. The findings, published in the May issue of Nature Genetics, open the door to developing treatment in coming years for people with a rare, inherited eye disorder.

GAINESVILLE, Fla. --- During World War I, the French army dispatched ammunition-carrying Briard dogs to the front lines. The Red Cross turned to the shaggy-haired sheepdogs to haul first-aid supplies.

Related Articles


And now Briards once again have been called to service: For the first time ever, animals that were born blind gained the ability to see after undergoing gene therapy, according to research from the University of Florida, Cornell University and the University of Pennsylvania. The findings, published in the May issue of Nature Genetics, open the door to developing treatment in coming years for people with a rare, inherited eye disorder.

The scientists reported their success in three dogs with a condition closely resembling Leber congenital amaurosis, or LCA, a blinding disease caused by mutations in a gene important for eye function. About 2,000 people in the United States have LCA, a currently untreatable condition that typically results in blindness from birth or shortly thereafter.

"In gene therapy with other eye diseases, we've been able to prevent worsening of the condition in animals, but this is the first time we've been able to recover a lost function," said William W. Hauswirth a contributing author who is the Rybaczki-Bullard professor of molecular genetics and microbiology at UF's College of Medicine.

"This is also really the first study that shows you can use gene therapy to get a response in a human-sized eye, that you can effectively treat enough of the retina to have an effect on the animal's visual function."

Dr. Jean Bennett, a senior author of the Nature Genetics paper and a scientist at the F.M. Kirby Center for Molecular Ophthalmology at Penn's Scheie Eye Institute, said the study results expand the possible treatment strategies for degenerative retinal diseases.

"We have worked hard for many, many years trying to develop a treatment for retinal degeneration, and this is the biggest leap forward yet," she said.

UF researchers had established that the apparently harmless adeno-associated virus can carry healthy copies of a gene into the cells of the retina, which is composed of layers of light-sensitive nerve cells. The healthy gene's mission: to produce a protein critical to translating light waves into nerve impulses that can be interpreted as images by the brain.

Scientists from Cornell and Penn, where the experiment was conducted, had identified the eye disease in the dogs and the mutated RPE65 gene responsible. The mutated RPE65 gene causes an estimated 15 percent of LCA cases, with the rest attributed to other mutations.

Efforts are under way to develop gene therapy approaches to combat those other mutations.

In the experiment, three Briard puppies had their right eyes treated late last year with a single injection of thousands of copies of the corrective gene in the virus provided by Hauswirth. Their left eyes were untreated as a control. The scientists planned to formally test eye function three months later, when the dogs were 6 months old.

"Well before those tests, the researchers thought the dogs could see because they kept turning their heads to the right to use the eye that had been treated," said Hauswirth, who also holds an appointment in the department of ophthalmology and is affiliated with UF's Genetics Institute and Powell Gene Therapy Center. "But then when the official tests were conducted, I got this very excited phone call, 'Bill, Bill, the dogs can see!'"

The tests showed that the treated eyes responded to light. The dogs also were able to navigate through a maze, even when the lighting was dim. "The dogs bumped into objects on the left side, but would always avoid the objects on the right," Hauswirth said.

Officials from the Foundation Fighting Blindness, which supported the study with grant funds, said the success in reversing blindness in dogs is an important advance. "With this study, gene therapy has overcome a major hurdle," said Gerald Chader the organization's chief scientific officer. "The Food and Drug Administration wants to see evidence that a treatment is safe and effective in a large animal model before granting permission to begin clinical trials in humans. Genetic medicine is now making things we could only once dream of a reality."

Hauswirth cautioned that it will take several years before the experimental treatment can be tested in people.

"This experiment showed us that this kind of therapy has potential to work, but now we need to go back and do very structured and rigorous tests to look for any signs of ill effects from the treatment," Hauswirth said. "And then in the early phase of testing in people, we also will be looking first at whether it causes any problems, rather than actually trying to reverse blindness."

LCA is an autosomal recessive disease, meaning that one copy of a mutated gene must be inherited from each parent to cause symptoms. Such mutations also occur in Briards and other dogs that have been inbred to preserve characteristics of their breed.

"The retina initially looks normal," Hauswirth said. "Over time, however, the retina starts losing part of its structure because there is no visual input. By the time a child is 10 or 15 years old, the light-sensitive photoreceptor cells are usually gone. At that point, putting in this gene isn't going to restore vision. So there almost certainly is going to be a window of treatability for LCA patients -- probably the younger the better."

In their next phase of animal testing, the scientists will try to pinpoint the time of life during which treatment might be effective. "That's such a critical question to deciding what populations in humans might benefit, although there's no guarantee that it will translate exactly to people," Hauswirth said. "No one really knows what dog years versus human years means in the eye."

The research effort continues to be supported by grants from the National Institutes of Health, the Foundation Fighting Blindness, Research to Prevent Blindness and the Macular Vision Research Foundation.


Story Source:

The above story is based on materials provided by University Of Florida. Note: Materials may be edited for content and length.


Cite This Page:

University Of Florida. "In Gene Therapy First, Scientists Restore Vision To Dogs Born Blind." ScienceDaily. ScienceDaily, 30 April 2001. <www.sciencedaily.com/releases/2001/04/010430072552.htm>.
University Of Florida. (2001, April 30). In Gene Therapy First, Scientists Restore Vision To Dogs Born Blind. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2001/04/010430072552.htm
University Of Florida. "In Gene Therapy First, Scientists Restore Vision To Dogs Born Blind." ScienceDaily. www.sciencedaily.com/releases/2001/04/010430072552.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins